Infertility Drugs Market Size, Share & Trends Analysis Report By Drug Class (Gonadotropins, Aromatase Inhibitors, SERMs, Dopamine Agonists) By End-user (Men, Women), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
This report can be delivered to the clients within 2 Business Days
Infertility Drugs Market Growth & Trends
The global infertility drugs market size is expected to reach USD 5.6 billion by 2030 expanding at a CAGR of 6.1% from 2023 to 2030 according to a new report by Grand View Research, Inc. The market seems to be saturated with fewer opportunities for new entrants. The companies including Merck & Co. Inc., Ferring B.V., and Organon group of companies holds majority of market share. Thus, the pharmaceutical companies are focusing on developing biosimilar of gonadotropins for market penetration. For instance, Qilu Pharmaceutical Co., Ltd. focuses on developing QL1012, a recombinant human follicle stimulating hormone which is under phase 3 clinical trial. Successful completion of of trial and subsequent launch is anticipated to drive market.
Increasing initiatives undertaken by public and private organizations to support patients living with infertility are expected to positively contribute to infertility treatment market growth. For instance, in March 2022, the French government introduced new IVF law under which single women and same sex-couple avail treatment free of cost under the country’s national healthcare system.
In addition, in November 2022, Saudi Arabia’s Health Insurance Council conducted studies with regard to the inclusion of medicines under medical insurance coverage. The successful completion of the study and inclusion of medication under insurance is anticipated to increase patient access to treatment, subsequently, increase demand for medicines over the forecast period.
Rising awareness about disease and its available medicines among patients and physicians is anticipated to increase the target population for the market. For instance, in September 2021, Mubadala Health and United Eastern Medical Services (UEMedical) organized the ‘3rd HealthPlus Middle East Fertility Conference with an aim to rise awareness about the advancements in the treatment of this conditions and its benefits among physicians and patients in Dubai.
Moreover, there are several initiatives undertaken by the national government worldwide to tackle low fertility rate issues and promote childbirth which may increase the demand for drugs. For instance, in August 2022, the South Korean Government announced a provision for a monthly allowance of USD 740 per new child born in the family with an aim to tackle the low fertility rate in the country and encourage childbirth.
Infertility Drugs Market Report Highlights
Infertility Drugs Market Growth & Trends
The global infertility drugs market size is expected to reach USD 5.6 billion by 2030 expanding at a CAGR of 6.1% from 2023 to 2030 according to a new report by Grand View Research, Inc. The market seems to be saturated with fewer opportunities for new entrants. The companies including Merck & Co. Inc., Ferring B.V., and Organon group of companies holds majority of market share. Thus, the pharmaceutical companies are focusing on developing biosimilar of gonadotropins for market penetration. For instance, Qilu Pharmaceutical Co., Ltd. focuses on developing QL1012, a recombinant human follicle stimulating hormone which is under phase 3 clinical trial. Successful completion of of trial and subsequent launch is anticipated to drive market.
Increasing initiatives undertaken by public and private organizations to support patients living with infertility are expected to positively contribute to infertility treatment market growth. For instance, in March 2022, the French government introduced new IVF law under which single women and same sex-couple avail treatment free of cost under the country’s national healthcare system.
In addition, in November 2022, Saudi Arabia’s Health Insurance Council conducted studies with regard to the inclusion of medicines under medical insurance coverage. The successful completion of the study and inclusion of medication under insurance is anticipated to increase patient access to treatment, subsequently, increase demand for medicines over the forecast period.
Rising awareness about disease and its available medicines among patients and physicians is anticipated to increase the target population for the market. For instance, in September 2021, Mubadala Health and United Eastern Medical Services (UEMedical) organized the ‘3rd HealthPlus Middle East Fertility Conference with an aim to rise awareness about the advancements in the treatment of this conditions and its benefits among physicians and patients in Dubai.
Moreover, there are several initiatives undertaken by the national government worldwide to tackle low fertility rate issues and promote childbirth which may increase the demand for drugs. For instance, in August 2022, the South Korean Government announced a provision for a monthly allowance of USD 740 per new child born in the family with an aim to tackle the low fertility rate in the country and encourage childbirth.
Infertility Drugs Market Report Highlights
- By drug class, the gonadotropin segment accounted for the largest share of the market in 2022 and is anticipated to witness fastest growth over the forecast period. This can be attributed to the availability of FDA-approved gonadotropins for infertility conditions in the market
- Based on end-user, the women segment dominated the infertility drugs market in 2022 owing to the rising incidence of the diseases such as PCOS, HPV associated vaginal cancer, uterine fibroids in women. As per the cohort studies published, in April 2022, approximately 1.5% of all French women aged 20 to 49 years were diagnosed with this condition annually.
- Hospiatal pharmacy segment dominated the infertility drugs market in 2022. This growth can be attributed to an increase in inpatient visits for the diagnosis and consulation of this condition worldwide
- North America dominated the global market in 2022 owing to factors such as high awareness among healthcare professionals about infertility conditions, ease of availability of drugs, and an increase in disease prevalence.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation and Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Snapshot
CHAPTER 3 INFERTILITY DRUGS: MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Market Lineage Outlook
3.1.1 Women's Health Market
3.2 Penetration and Growth Prospect Mapping
3.3 Regulatory Landscape
3.4 Market Dynamics
3.5 Market Driver Analysis
3.5.1 Rising burden of infertility
3.5.2 Presence of strong product pipeline
3.5.3 Increasing funding for infertility R&D
3.6 Market Restraint Analysis
3.6.1. Unsupportive Government Regulations for Infertility Drugs
3.7 PESTEL Analysis
3.8 Industry Analysis-Porter’s Five Forces
3.9 Pipeline Analysis
CHAPTER 4 INFERTILITY DRUGS MARKET: SEGMENT ANALYSIS, BY DRUG CLASS, 2018 - 2030 (USD MILLION)
4.1 Infertility Drugs Market: Drug Class Movement Analysis
4.2 Gonadotropins
4.2.1 Gonadotropins Market, 2018 - 2030 (USD Million)
4.2.2 Aromatase Inhibitors
4.2.2.1 Aromatase Inhibitors Market, 2018 - 2030 (USD Million)
4.2.3 Selective Estrogen Receptor Modulators (SERMs)
4.2.3.1 Selective Estrogen Receptor Modulators (SERMs) Market, 2018 - 2030 (USD Million)
4.2.4 Dopamine Agonists
4.2.4.1 Dopamine Agonists Market, 2018 - 2030 (USD Million)
4.2.5 Others
4.2.5.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 5 INFERTILITY DRUGS MARKET: SEGMENT ANALYSIS, BY DISTRIBUTION CHANNEL, 2018 - 2030 (USD MILLION)
5.1 Infertility Drugs Market: Distribution Channel Movement Analysis
5.2 Hospital Pharmacy
5.2.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
5.3 Specialty & Retail Pharmacy
5.3.1 Specialty & Retail Pharmacy Market, 2018 - 2030 (USD Million)
5.4 Online Pharmacy
5.4.1 Online Pharmacy Market, 2018 - 2030 (USD Million)
CHAPTER 6 INFERTILITY DRUGS MARKET: SEGMENT ANALYSIS, BY END-USER, 2018 - 2030 (USD MILLION)
6.1 Infertility Drugs Market: End-User Movement Analysis
6.2 Men
6.2.1 Men Market, 2018 - 2030 (USD Million)
6.3 Women
6.3.1 Women Market, 2018 - 2030 (USD Million)
CHAPTER 7 INFERTILITY DRUGS MARKET: REGIONAL ESTIMATES AND TREND ANALYSIS
7.1 North America
7.1.1 SWOT Analysis:
7.1.1.1 North America Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.1.2 U.S.
7.1.2.1 Key Country Dynamics
7.1.2.2 Target Disease Prevalence
7.1.2.3 Competitive Scenario
7.1.2.4 Regulatory Framework
7.1.2.5 Reimbursement Scenario
7.1.2.6 U.S. Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.1.3 Canada
7.1.3.1 Key Country Dynamics
7.1.3.2 Target Disease Prevalence
7.1.3.3 Competitive Scenario
7.1.3.4 Regulatory Framework
7.1.3.5 Reimbursement Scenario
7.1.3.6 Canada Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2 Europe
7.2.1 SWOT Analysis:
7.2.1.1 Europe Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2 UK
7.2.2.1 Key Country Dynamics
7.2.2.2 Target Disease Prevalence
7.2.2.3 Competitive Scenario
7.2.2.4 Regulatory Framework
7.2.2.5 Reimbursement Scenario
7.2.2.6 Prescription and Dispensing Scenario
7.2.2.7 UK Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3 Germany
7.2.3.1 Key Country Dynamics
7.2.3.2 Target Disease Prevalence
7.2.3.3 Competitive Scenario
7.2.3.4 Regulatory Framework
7.2.3.5 Reimbursement Scenario
7.2.3.6 Germany Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4 France
7.2.4.1 Key Country Dynamics
7.2.4.2 Target Disease Prevalence
7.2.4.3 Competitive Scenario
7.2.4.4 Regulatory Framework
7.2.4.5 Reimbursement Scenario
7.2.4.6 France Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.5 Italy
7.2.5.1 Key Country Dynamics
7.2.5.2 Target Disease Prevalence
7.2.5.3 Competitive Scenario
7.2.5.4 Regulatory Framework
7.2.5.5 Reimbursement Scenario
7.2.5.6 Italy Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.6 Spain
7.2.6.1 Key Country Dynamics
7.2.6.2 Target Disease Prevalence
7.2.6.3 Competitive Scenario
7.2.6.4 Regulatory Framework
7.2.6.5 Reimbursement Scenario
7.2.6.6 Spain Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.7 Denmark
7.2.7.1 Key Country Dynamics
7.2.7.2 Target Disease Prevalence
7.2.7.3 Competitive Scenario
7.2.7.4 Regulatory Framework
7.2.7.5 Reimbursement Scenario
7.2.7.6 Denmark Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.8 Sweden
7.2.8.1 Key Country Dynamics
7.2.8.2 Target Disease Prevalence
7.2.8.3 Competitive Scenario
7.2.8.4 Regulatory Framework
7.2.8.5 Reimbursement Scenario
7.2.8.6 Sweden Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.9 Norway
7.2.9.1 Key Country Dynamics
7.2.9.2 Target Disease Prevalence
7.2.9.3 Competitive Scenario
7.2.9.4 Regulatory Framework
7.2.9.5 Reimbursement Scenario
7.2.9.6 Norway Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.9 Rest of Europe Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Asia Pacific
7.3.1 SWOT Analysis:
7.3.1.1 Asia Pacific Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2 Japan
7.3.2.1 Key Country Dynamics
7.3.2.2 Target Disease Prevalence
7.3.2.3 Competitive Scenario
7.3.2.4 Regulatory Framework
7.3.2.5 Reimbursement Scenario
7.3.2.6 Prescription and Dispensing Scenario
7.3.2.7 Japan Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3 China
7.3.3.1 Key Country Dynamics
7.3.3.2 Target Disease Prevalence
7.3.3.3 Competitive Scenario
7.3.3.4 Regulatory Framework
7.3.3.5 Reimbursement Scenario
7.3.3.6 China Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4 India
7.3.4.1 Key Country Dynamics
7.3.4.2 Target Disease Prevalence
7.3.4.3 Competitive Scenario
7.3.4.4 Regulatory Framework
7.3.4.5 Reimbursement Scenario
7.3.4.6 India Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5 Australia
7.3.5.1 Key Country Dynamics
7.3.5.2 Target Disease Prevalence
7.3.5.3 Competitive Scenario
7.3.5.4 Regulatory Framework
7.3.5.5 Reimbursement Scenario
7.3.5.6 Australia Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6 South Korea
7.3.6.1 Key Country Dynamics
7.3.6.2 Target Disease Prevalence
7.3.6.3 Competitive Scenario
7.3.6.4 Regulatory Framework
7.3.6.5 Reimbursement Scenario
7.3.6.6 South Korea Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7 Thailand
7.3.7.1 Key Country Dynamics
7.3.7.2 Target Disease Prevalence
7.3.7.3 Competitive Scenario
7.3.7.4 Regulatory Framework
7.3.7.5 Reimbursement Scenario
7.3.7.6 Thailand Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8 Rest of APAC Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Latin America
7.4.1 SWOT Analysis:
7.4.1.1 Latin America Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2 Brazil
7.4.2.1 Key Country Dynamics
7.4.2.2 Target Disease Prevalence
7.4.2.3 Competitive Scenario
7.4.2.4 Regulatory Framework
7.4.2.5 Reimbursement Scenario
7.4.2.6 Prescription and Dispensing Scenario
7.4.2.7 Brazil Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3 Mexico
7.4.3.1 Key Country Dynamics
7.4.3.2 Target Disease Prevalence
7.4.3.3 Competitive Scenario
7.4.3.4 Regulatory Framework
7.4.3.5 Reimbursement Scenario
7.4.3.6 Mexico Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4 Argentina
7.4.4.1 Key Country Dynamics
7.4.4.2 Target Disease Prevalence
7.4.4.3 Competitive Scenario
7.4.4.4 Regulatory Framework
7.4.4.5 Reimbursement Scenario
7.4.4.6 Argentina Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. Rest of Latin America Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Middle East & Africa (MEA)
7.5.1 SWOT Analysis:
7.5.1.1 MEA Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2 South Africa
7.5.2.1 Key Country Dynamics
7.5.2.2 Target Disease Prevalence
7.5.2.3 Competitive Scenario
7.5.2.4 Regulatory Framework
7.5.2.5 Reimbursement Scenario
7.5.2.6 Prescription and Dispensing Scenario
7.5.2.7 South Africa Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3 Saudi Arabia
7.5.3.1 Key Country Dynamics
7.5.3.2 Target Disease Prevalence
7.5.3.3 Competitive Scenario
7.5.3.4 Regulatory Framework
7.5.3.5 Reimbursement Scenario
7.5.3.6 Saudi Arabia Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4 UAE
7.5.4.1 Key Country Dynamics
7.5.4.2 Target Disease Prevalence
7.5.4.3 Competitive Scenario
7.5.4.4 Regulatory Framework
7.5.4.5 Reimbursement Scenario
7.5.4.6 UAE Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5 Kuwait
7.5.5.1 Key Country Dynamics
7.5.5.2 Target Disease Prevalence
7.5.5.3 Competitive Scenario
7.5.5.4 Regulatory Framework
7.5.5.5 Reimbursement Scenario
7.5.5.6 Kuwait Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6 Rest of MEA Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8 INFERTILITY DRUGS MARKET: COMPETITIVE ANALYSIS
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.1.1 New Product Launch
8.1.2 Merger and Acquisition
8.1.3 Licensing Agreements
8.1.4 Conferences and Campaigns
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Vendor Landscape
8.3.1 List of Key Distributors and Channel Partners
8.3.2 Key Customers
8.4 Public Companies
8.4.1 Key Company Market Share Analysis, 2021
8.4.2 Company Market Position Analysis
8.4.3 Heat Map Analysis
8.4.4 Competitive Dashboard Analysis
8.4.4.1 Market Differentiators
8.5 Private Companies
8.5.1 List of Key Emerging Companies
8.5.2 Regional Network Map
8.6 Company Profiles
8.6.1.Bayer AG
8.6.1.1 Company Overview
8.6.1.2 Financial Performance
8.6.1.3 Product Benchmarking
8.6.1.4 Strategic Initiatives
8.6.2 Novartis AG
8.6.2.1 Company Overview
8.6.2.2 Financial Performance
8.6.2.3 Product Benchmarking
8.6.2.4 Strategic Initiatives
8.6.3 Merck & Co., Inc.
8.6.3.1 Company Overview
8.6.3.2 Financial Performance
8.6.3.3 Product Benchmarking
8.6.3.4 Strategic Initiatives
8.6.4 Ferring B.V.
8.6.4.1 Company Overview
8.6.4.2 Financial Performance
8.6.4.3 Product Benchmarking
8.6.4.4 Strategic Initiatives
8.6.5 Pfizer Inc.
8.6.5.1 Company Overview
8.6.5.2 Financial Performance
8.6.5.3 Product Benchmarking
8.6.5.4 Strategic Initiatives
8.6.6 Mankind Pharma
8.6.6.1 Company Overview
8.6.6.2 Financial Performance
8.6.6.3 Product Benchmarking
8.6.6.4 Strategic Initiatives
8.6.7 Teva Pharmaceutical Industries LTD.
8.6.7.1 Company Overview
8.6.7.2 Financial Performance
8.6.7.3 Product Benchmarking
8.6.7.4 Strategic Initiatives
8.6.8 Sanofi
8.6.8.1 Company Overview
8.6.8.2 Financial Performance
8.6.8.3 Product Benchmarking
8.6.8.4 Strategic Initiatives
8.6.9 Abbott
8.6.8.1 Company Overview
8.6.9.2 Financial Performance
8.6.9.3 Product Benchmarking
8.6.9.4 Strategic Initiatives
8.6.10 Organon Group of Countries
8.6.10.1 Company Overview
8.6.10.2 Product Benchmarking
8.6.10.3 Strategic Initiatives
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation and Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Snapshot
CHAPTER 3 INFERTILITY DRUGS: MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Market Lineage Outlook
3.1.1 Women's Health Market
3.2 Penetration and Growth Prospect Mapping
3.3 Regulatory Landscape
3.4 Market Dynamics
3.5 Market Driver Analysis
3.5.1 Rising burden of infertility
3.5.2 Presence of strong product pipeline
3.5.3 Increasing funding for infertility R&D
3.6 Market Restraint Analysis
3.6.1. Unsupportive Government Regulations for Infertility Drugs
3.7 PESTEL Analysis
3.8 Industry Analysis-Porter’s Five Forces
3.9 Pipeline Analysis
CHAPTER 4 INFERTILITY DRUGS MARKET: SEGMENT ANALYSIS, BY DRUG CLASS, 2018 - 2030 (USD MILLION)
4.1 Infertility Drugs Market: Drug Class Movement Analysis
4.2 Gonadotropins
4.2.1 Gonadotropins Market, 2018 - 2030 (USD Million)
4.2.2 Aromatase Inhibitors
4.2.2.1 Aromatase Inhibitors Market, 2018 - 2030 (USD Million)
4.2.3 Selective Estrogen Receptor Modulators (SERMs)
4.2.3.1 Selective Estrogen Receptor Modulators (SERMs) Market, 2018 - 2030 (USD Million)
4.2.4 Dopamine Agonists
4.2.4.1 Dopamine Agonists Market, 2018 - 2030 (USD Million)
4.2.5 Others
4.2.5.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 5 INFERTILITY DRUGS MARKET: SEGMENT ANALYSIS, BY DISTRIBUTION CHANNEL, 2018 - 2030 (USD MILLION)
5.1 Infertility Drugs Market: Distribution Channel Movement Analysis
5.2 Hospital Pharmacy
5.2.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
5.3 Specialty & Retail Pharmacy
5.3.1 Specialty & Retail Pharmacy Market, 2018 - 2030 (USD Million)
5.4 Online Pharmacy
5.4.1 Online Pharmacy Market, 2018 - 2030 (USD Million)
CHAPTER 6 INFERTILITY DRUGS MARKET: SEGMENT ANALYSIS, BY END-USER, 2018 - 2030 (USD MILLION)
6.1 Infertility Drugs Market: End-User Movement Analysis
6.2 Men
6.2.1 Men Market, 2018 - 2030 (USD Million)
6.3 Women
6.3.1 Women Market, 2018 - 2030 (USD Million)
CHAPTER 7 INFERTILITY DRUGS MARKET: REGIONAL ESTIMATES AND TREND ANALYSIS
7.1 North America
7.1.1 SWOT Analysis:
7.1.1.1 North America Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.1.2 U.S.
7.1.2.1 Key Country Dynamics
7.1.2.2 Target Disease Prevalence
7.1.2.3 Competitive Scenario
7.1.2.4 Regulatory Framework
7.1.2.5 Reimbursement Scenario
7.1.2.6 U.S. Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.1.3 Canada
7.1.3.1 Key Country Dynamics
7.1.3.2 Target Disease Prevalence
7.1.3.3 Competitive Scenario
7.1.3.4 Regulatory Framework
7.1.3.5 Reimbursement Scenario
7.1.3.6 Canada Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2 Europe
7.2.1 SWOT Analysis:
7.2.1.1 Europe Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2 UK
7.2.2.1 Key Country Dynamics
7.2.2.2 Target Disease Prevalence
7.2.2.3 Competitive Scenario
7.2.2.4 Regulatory Framework
7.2.2.5 Reimbursement Scenario
7.2.2.6 Prescription and Dispensing Scenario
7.2.2.7 UK Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3 Germany
7.2.3.1 Key Country Dynamics
7.2.3.2 Target Disease Prevalence
7.2.3.3 Competitive Scenario
7.2.3.4 Regulatory Framework
7.2.3.5 Reimbursement Scenario
7.2.3.6 Germany Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4 France
7.2.4.1 Key Country Dynamics
7.2.4.2 Target Disease Prevalence
7.2.4.3 Competitive Scenario
7.2.4.4 Regulatory Framework
7.2.4.5 Reimbursement Scenario
7.2.4.6 France Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.5 Italy
7.2.5.1 Key Country Dynamics
7.2.5.2 Target Disease Prevalence
7.2.5.3 Competitive Scenario
7.2.5.4 Regulatory Framework
7.2.5.5 Reimbursement Scenario
7.2.5.6 Italy Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.6 Spain
7.2.6.1 Key Country Dynamics
7.2.6.2 Target Disease Prevalence
7.2.6.3 Competitive Scenario
7.2.6.4 Regulatory Framework
7.2.6.5 Reimbursement Scenario
7.2.6.6 Spain Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.7 Denmark
7.2.7.1 Key Country Dynamics
7.2.7.2 Target Disease Prevalence
7.2.7.3 Competitive Scenario
7.2.7.4 Regulatory Framework
7.2.7.5 Reimbursement Scenario
7.2.7.6 Denmark Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.8 Sweden
7.2.8.1 Key Country Dynamics
7.2.8.2 Target Disease Prevalence
7.2.8.3 Competitive Scenario
7.2.8.4 Regulatory Framework
7.2.8.5 Reimbursement Scenario
7.2.8.6 Sweden Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.9 Norway
7.2.9.1 Key Country Dynamics
7.2.9.2 Target Disease Prevalence
7.2.9.3 Competitive Scenario
7.2.9.4 Regulatory Framework
7.2.9.5 Reimbursement Scenario
7.2.9.6 Norway Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.9 Rest of Europe Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Asia Pacific
7.3.1 SWOT Analysis:
7.3.1.1 Asia Pacific Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2 Japan
7.3.2.1 Key Country Dynamics
7.3.2.2 Target Disease Prevalence
7.3.2.3 Competitive Scenario
7.3.2.4 Regulatory Framework
7.3.2.5 Reimbursement Scenario
7.3.2.6 Prescription and Dispensing Scenario
7.3.2.7 Japan Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3 China
7.3.3.1 Key Country Dynamics
7.3.3.2 Target Disease Prevalence
7.3.3.3 Competitive Scenario
7.3.3.4 Regulatory Framework
7.3.3.5 Reimbursement Scenario
7.3.3.6 China Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4 India
7.3.4.1 Key Country Dynamics
7.3.4.2 Target Disease Prevalence
7.3.4.3 Competitive Scenario
7.3.4.4 Regulatory Framework
7.3.4.5 Reimbursement Scenario
7.3.4.6 India Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5 Australia
7.3.5.1 Key Country Dynamics
7.3.5.2 Target Disease Prevalence
7.3.5.3 Competitive Scenario
7.3.5.4 Regulatory Framework
7.3.5.5 Reimbursement Scenario
7.3.5.6 Australia Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6 South Korea
7.3.6.1 Key Country Dynamics
7.3.6.2 Target Disease Prevalence
7.3.6.3 Competitive Scenario
7.3.6.4 Regulatory Framework
7.3.6.5 Reimbursement Scenario
7.3.6.6 South Korea Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7 Thailand
7.3.7.1 Key Country Dynamics
7.3.7.2 Target Disease Prevalence
7.3.7.3 Competitive Scenario
7.3.7.4 Regulatory Framework
7.3.7.5 Reimbursement Scenario
7.3.7.6 Thailand Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8 Rest of APAC Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Latin America
7.4.1 SWOT Analysis:
7.4.1.1 Latin America Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2 Brazil
7.4.2.1 Key Country Dynamics
7.4.2.2 Target Disease Prevalence
7.4.2.3 Competitive Scenario
7.4.2.4 Regulatory Framework
7.4.2.5 Reimbursement Scenario
7.4.2.6 Prescription and Dispensing Scenario
7.4.2.7 Brazil Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3 Mexico
7.4.3.1 Key Country Dynamics
7.4.3.2 Target Disease Prevalence
7.4.3.3 Competitive Scenario
7.4.3.4 Regulatory Framework
7.4.3.5 Reimbursement Scenario
7.4.3.6 Mexico Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4 Argentina
7.4.4.1 Key Country Dynamics
7.4.4.2 Target Disease Prevalence
7.4.4.3 Competitive Scenario
7.4.4.4 Regulatory Framework
7.4.4.5 Reimbursement Scenario
7.4.4.6 Argentina Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. Rest of Latin America Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Middle East & Africa (MEA)
7.5.1 SWOT Analysis:
7.5.1.1 MEA Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2 South Africa
7.5.2.1 Key Country Dynamics
7.5.2.2 Target Disease Prevalence
7.5.2.3 Competitive Scenario
7.5.2.4 Regulatory Framework
7.5.2.5 Reimbursement Scenario
7.5.2.6 Prescription and Dispensing Scenario
7.5.2.7 South Africa Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3 Saudi Arabia
7.5.3.1 Key Country Dynamics
7.5.3.2 Target Disease Prevalence
7.5.3.3 Competitive Scenario
7.5.3.4 Regulatory Framework
7.5.3.5 Reimbursement Scenario
7.5.3.6 Saudi Arabia Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4 UAE
7.5.4.1 Key Country Dynamics
7.5.4.2 Target Disease Prevalence
7.5.4.3 Competitive Scenario
7.5.4.4 Regulatory Framework
7.5.4.5 Reimbursement Scenario
7.5.4.6 UAE Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5 Kuwait
7.5.5.1 Key Country Dynamics
7.5.5.2 Target Disease Prevalence
7.5.5.3 Competitive Scenario
7.5.5.4 Regulatory Framework
7.5.5.5 Reimbursement Scenario
7.5.5.6 Kuwait Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6 Rest of MEA Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8 INFERTILITY DRUGS MARKET: COMPETITIVE ANALYSIS
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.1.1 New Product Launch
8.1.2 Merger and Acquisition
8.1.3 Licensing Agreements
8.1.4 Conferences and Campaigns
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Vendor Landscape
8.3.1 List of Key Distributors and Channel Partners
8.3.2 Key Customers
8.4 Public Companies
8.4.1 Key Company Market Share Analysis, 2021
8.4.2 Company Market Position Analysis
8.4.3 Heat Map Analysis
8.4.4 Competitive Dashboard Analysis
8.4.4.1 Market Differentiators
8.5 Private Companies
8.5.1 List of Key Emerging Companies
8.5.2 Regional Network Map
8.6 Company Profiles
8.6.1.Bayer AG
8.6.1.1 Company Overview
8.6.1.2 Financial Performance
8.6.1.3 Product Benchmarking
8.6.1.4 Strategic Initiatives
8.6.2 Novartis AG
8.6.2.1 Company Overview
8.6.2.2 Financial Performance
8.6.2.3 Product Benchmarking
8.6.2.4 Strategic Initiatives
8.6.3 Merck & Co., Inc.
8.6.3.1 Company Overview
8.6.3.2 Financial Performance
8.6.3.3 Product Benchmarking
8.6.3.4 Strategic Initiatives
8.6.4 Ferring B.V.
8.6.4.1 Company Overview
8.6.4.2 Financial Performance
8.6.4.3 Product Benchmarking
8.6.4.4 Strategic Initiatives
8.6.5 Pfizer Inc.
8.6.5.1 Company Overview
8.6.5.2 Financial Performance
8.6.5.3 Product Benchmarking
8.6.5.4 Strategic Initiatives
8.6.6 Mankind Pharma
8.6.6.1 Company Overview
8.6.6.2 Financial Performance
8.6.6.3 Product Benchmarking
8.6.6.4 Strategic Initiatives
8.6.7 Teva Pharmaceutical Industries LTD.
8.6.7.1 Company Overview
8.6.7.2 Financial Performance
8.6.7.3 Product Benchmarking
8.6.7.4 Strategic Initiatives
8.6.8 Sanofi
8.6.8.1 Company Overview
8.6.8.2 Financial Performance
8.6.8.3 Product Benchmarking
8.6.8.4 Strategic Initiatives
8.6.9 Abbott
8.6.8.1 Company Overview
8.6.9.2 Financial Performance
8.6.9.3 Product Benchmarking
8.6.9.4 Strategic Initiatives
8.6.10 Organon Group of Countries
8.6.10.1 Company Overview
8.6.10.2 Product Benchmarking
8.6.10.3 Strategic Initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global Infertility Drugs Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 6 Global Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 7 Global Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 8 North America Infertility Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 10 North America Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 11 North America Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 12 U.S. Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 13 U.S. Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 14 U.S. Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 15 Canada Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 16 Canada Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 17 Canada Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 18 Europe Infertility Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 19 Europe Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 20 Europe Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 21 Europe Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 22 Germany Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 23 Germany Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 24 Germany Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 25 UK Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 26 UK Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 27 UK Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 28 France Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 29 France Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 30 France Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 31 Italy Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 32 Italy Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 33 Italy Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 34 Spain Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 35 Spain Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 36 Spain Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 37 Denmark Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 38 Denmark Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 39 Denmark Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Sweden Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 41 Sweden Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 42 Sweden Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 43 Norway Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 44 Norway Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 45 Norway Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Infertility Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 50 Japan Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 51 Japan Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 52 Japan Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 53 China Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 54 China Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 55 China Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 56 India Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 57 India Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 58 India Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 59 South Korea Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 60 South Korea Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 61 South Korea Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 62 Australia Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 63 Australia Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 64 Australia Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 65 Thailand Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 66 Thailand Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 67 Thailand Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 68 Latin America Infertility Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 69 Latin America Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 70 Latin America Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 71 Latin America Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 72 Brazil Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 73 Brazil Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 74 Brazil Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 75 Mexico Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 76 Mexico Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 77 Mexico Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 78 Argentina Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 79 Argentina Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 80 Argentina Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Infertility Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 84 Middle East & Africa Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 88 South Africa Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 89 South Africa Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 90 South Africa Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 91 UAE Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 92 UAE Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 93 UAE Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 94 Kuwait Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 95 Kuwait Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 96 Kuwait Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global Infertility Drugs Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 6 Global Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 7 Global Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 8 North America Infertility Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 10 North America Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 11 North America Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 12 U.S. Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 13 U.S. Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 14 U.S. Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 15 Canada Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 16 Canada Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 17 Canada Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 18 Europe Infertility Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 19 Europe Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 20 Europe Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 21 Europe Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 22 Germany Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 23 Germany Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 24 Germany Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 25 UK Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 26 UK Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 27 UK Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 28 France Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 29 France Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 30 France Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 31 Italy Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 32 Italy Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 33 Italy Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 34 Spain Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 35 Spain Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 36 Spain Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 37 Denmark Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 38 Denmark Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 39 Denmark Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Sweden Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 41 Sweden Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 42 Sweden Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 43 Norway Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 44 Norway Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 45 Norway Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Infertility Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 50 Japan Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 51 Japan Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 52 Japan Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 53 China Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 54 China Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 55 China Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 56 India Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 57 India Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 58 India Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 59 South Korea Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 60 South Korea Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 61 South Korea Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 62 Australia Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 63 Australia Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 64 Australia Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 65 Thailand Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 66 Thailand Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 67 Thailand Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 68 Latin America Infertility Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 69 Latin America Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 70 Latin America Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 71 Latin America Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 72 Brazil Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 73 Brazil Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 74 Brazil Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 75 Mexico Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 76 Mexico Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 77 Mexico Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 78 Argentina Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 79 Argentina Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 80 Argentina Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Infertility Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 84 Middle East & Africa Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 88 South Africa Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 89 South Africa Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 90 South Africa Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 91 UAE Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 92 UAE Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 93 UAE Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 94 Kuwait Infertility Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
Table 95 Kuwait Infertility Drugs Market, By End-User, 2018 - 2030 (USD Million)
Table 96 Kuwait Infertility Drugs Market, By Distribution Channel, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Infertility Drugs Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Data Triangulation Techniques
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 QFD Modeling for Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Commodity Flow Analysis
Fig. 10 Market Snapshot (2022) (USD Million)
Fig. 11 Segment Snapshot (2022) (USD Million)
Fig. 12 Segment Snapshot (2022) (USD Million)
Fig. 13 Competitive Snapshot
Fig. 14 Penetration and Growth Prospect Mapping
Fig. 15 Infertility Drugs Market Driver Impact
Fig. 16 Infertility Drugs Market Restraint Impact
Fig. 17 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Fig. 18 Porter’s Five Forces Analysis
Fig. 19 Infertility Drugs Market: Drug Class Outlook and Key Takeaways
Fig. 20 Infertility Drugs Market: Drug Class Movement Analysis
Fig. 21 Gonadotropins Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 22 Aromatase Inhibitors Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 23 Selective Estrogen Receptor Modulators (SERMs) Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 24 Dopamine Agonists Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 25 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 26 Infertility Drugs Market: Distribution Channe Outlook and Key Takeaways
Fig. 27 Infertility Drugs Market: Distribution Channel Movement Analysis
Fig. 28 Hospital Pharmacy Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 29 Specialty & Retail Pharmacy Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 30 Online Pharmacy Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 31 Infertility Drugs Market: End-User Outlook and Key Takeaways
Fig. 32 Infertility Drugs Market: End-User Movement Analysis
Fig. 33 Men Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 34 Women Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 35 Regional Marketplace: Key Takeaways
Fig. 36 North America: SWOT analysis
Fig. 37 North America Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 38 U.S. Key Country Dynamics
Fig. 39 U.S. Target Disease Prevalence
Fig. 40 U.S. Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 41 Canada Key Country Dynamics
Fig. 42 Canada Target Disease Prevalence
Fig. 43 Canada Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 44 Europe: SWOT analysis
Fig. 45 Europe Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 46 Germany Key Country Dynamics
Fig. 47 Germany Target Disease Prevalence
Fig. 48 Germany Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 49 UK Key Country Dynamics
Fig. 50 UK Target Disease Prevalence
Fig. 51 UK Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 52 France Key Country Dynamics
Fig. 53 France Target Disease Prevalence
Fig. 54 France Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 55 Italy Key Country Dynamics
Fig. 56 Italy Target Disease Prevalence
Fig. 57 Italy Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 58 Spain Key Country Dynamics
Fig. 59 Spain Target Disease Prevalence
Fig. 60 Spain Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 61 Denmark Key Country Dynamics
Fig. 62 Denmark Target Disease Prevalence
Fig. 63 Denmark Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 64 Sweden Key Country Dynamics
Fig. 65 Sweden Target Disease Prevalence
Fig. 66 Sweden Infertility Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Norway Key Country Dynamics
Fig. 68 Norway Target Disease Prevalence
Fig. 69 Norway Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 70 Rest of Europe Infertility Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Asia Pacific: SWOT Analysis
Fig. 72 Asia Pacific Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 73 Japan Key Country Dynamics
Fig. 74 Japan Target Disease Prevalence
Fig. 75 Japan Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 76 China Key Country Dynamics
Fig. 77 China Target Disease Prevalence
Fig. 78 China Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 79 India Key Country Dynamics
Fig. 80 India Target Disease Prevalence
Fig. 81 India Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 82 Australia Key Country Dynamics
Fig. 83 Australia Target Disease Prevalence
Fig. 84 Australia Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 85 South Korea Key Country Dynamics
Fig. 86 South Korea Target Disease Prevalence
Fig. 87 South Korea Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 88 Thailand Key Country Dynamics
Fig. 89 Thailand Target Disease Prevalence
Fig. 90 Thailand Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 91 Rest of APAC Infertility Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Latin America (LATAM): SWOT Analysis
Fig. 93 Latin America Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 94 Brazil Key Country Dynamics
Fig. 95 Brazil Target Disease Prevalence
Fig. 96 Brazil Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 97 Mexico Key Country Dynamics
Fig. 98 Mexico Target Disease Prevalence
Fig. 99 Mexico Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 100 Argentina Key Country Dynamics
Fig. 101 Argentina Target Disease Prevalence
Fig. 102 Argentina Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 103 Rest of LATAM Infertility Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Middle East & Africa (MEA): SWOT Analysis
Fig. 105 Middle East & Africa (MEA) Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 106 South Africa Key Country Dynamics
Fig. 107 Target Disease Prevalence
Fig. 108 South Africa Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 109 Saudi Arabia Key country dynamics
Fig. 110 Saudi Arabia Target Disease Prevalence
Fig. 111 Saudi Arabia Infertility Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 112 UAE Key Country Dynamics
Fig. 113 UAE Target Disease Prevalence
Fig. 114 UAE Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 115 Kuwait Key Country Dynamics
Fig. 116 Kuwait Target Disease Prevalence
Fig. 117 Kuwait Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 118 Rest of MEA Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 119 Heat Map Analysis
Fig. 120 Strategic Framework
Fig. 1 Infertility Drugs Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Data Triangulation Techniques
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 QFD Modeling for Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Commodity Flow Analysis
Fig. 10 Market Snapshot (2022) (USD Million)
Fig. 11 Segment Snapshot (2022) (USD Million)
Fig. 12 Segment Snapshot (2022) (USD Million)
Fig. 13 Competitive Snapshot
Fig. 14 Penetration and Growth Prospect Mapping
Fig. 15 Infertility Drugs Market Driver Impact
Fig. 16 Infertility Drugs Market Restraint Impact
Fig. 17 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Fig. 18 Porter’s Five Forces Analysis
Fig. 19 Infertility Drugs Market: Drug Class Outlook and Key Takeaways
Fig. 20 Infertility Drugs Market: Drug Class Movement Analysis
Fig. 21 Gonadotropins Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 22 Aromatase Inhibitors Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 23 Selective Estrogen Receptor Modulators (SERMs) Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 24 Dopamine Agonists Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 25 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 26 Infertility Drugs Market: Distribution Channe Outlook and Key Takeaways
Fig. 27 Infertility Drugs Market: Distribution Channel Movement Analysis
Fig. 28 Hospital Pharmacy Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 29 Specialty & Retail Pharmacy Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 30 Online Pharmacy Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 31 Infertility Drugs Market: End-User Outlook and Key Takeaways
Fig. 32 Infertility Drugs Market: End-User Movement Analysis
Fig. 33 Men Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 34 Women Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 35 Regional Marketplace: Key Takeaways
Fig. 36 North America: SWOT analysis
Fig. 37 North America Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 38 U.S. Key Country Dynamics
Fig. 39 U.S. Target Disease Prevalence
Fig. 40 U.S. Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 41 Canada Key Country Dynamics
Fig. 42 Canada Target Disease Prevalence
Fig. 43 Canada Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 44 Europe: SWOT analysis
Fig. 45 Europe Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 46 Germany Key Country Dynamics
Fig. 47 Germany Target Disease Prevalence
Fig. 48 Germany Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 49 UK Key Country Dynamics
Fig. 50 UK Target Disease Prevalence
Fig. 51 UK Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 52 France Key Country Dynamics
Fig. 53 France Target Disease Prevalence
Fig. 54 France Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 55 Italy Key Country Dynamics
Fig. 56 Italy Target Disease Prevalence
Fig. 57 Italy Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 58 Spain Key Country Dynamics
Fig. 59 Spain Target Disease Prevalence
Fig. 60 Spain Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 61 Denmark Key Country Dynamics
Fig. 62 Denmark Target Disease Prevalence
Fig. 63 Denmark Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 64 Sweden Key Country Dynamics
Fig. 65 Sweden Target Disease Prevalence
Fig. 66 Sweden Infertility Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Norway Key Country Dynamics
Fig. 68 Norway Target Disease Prevalence
Fig. 69 Norway Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 70 Rest of Europe Infertility Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Asia Pacific: SWOT Analysis
Fig. 72 Asia Pacific Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 73 Japan Key Country Dynamics
Fig. 74 Japan Target Disease Prevalence
Fig. 75 Japan Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 76 China Key Country Dynamics
Fig. 77 China Target Disease Prevalence
Fig. 78 China Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 79 India Key Country Dynamics
Fig. 80 India Target Disease Prevalence
Fig. 81 India Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 82 Australia Key Country Dynamics
Fig. 83 Australia Target Disease Prevalence
Fig. 84 Australia Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 85 South Korea Key Country Dynamics
Fig. 86 South Korea Target Disease Prevalence
Fig. 87 South Korea Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 88 Thailand Key Country Dynamics
Fig. 89 Thailand Target Disease Prevalence
Fig. 90 Thailand Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 91 Rest of APAC Infertility Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Latin America (LATAM): SWOT Analysis
Fig. 93 Latin America Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 94 Brazil Key Country Dynamics
Fig. 95 Brazil Target Disease Prevalence
Fig. 96 Brazil Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 97 Mexico Key Country Dynamics
Fig. 98 Mexico Target Disease Prevalence
Fig. 99 Mexico Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 100 Argentina Key Country Dynamics
Fig. 101 Argentina Target Disease Prevalence
Fig. 102 Argentina Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 103 Rest of LATAM Infertility Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Middle East & Africa (MEA): SWOT Analysis
Fig. 105 Middle East & Africa (MEA) Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 106 South Africa Key Country Dynamics
Fig. 107 Target Disease Prevalence
Fig. 108 South Africa Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 109 Saudi Arabia Key country dynamics
Fig. 110 Saudi Arabia Target Disease Prevalence
Fig. 111 Saudi Arabia Infertility Drugs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 112 UAE Key Country Dynamics
Fig. 113 UAE Target Disease Prevalence
Fig. 114 UAE Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 115 Kuwait Key Country Dynamics
Fig. 116 Kuwait Target Disease Prevalence
Fig. 117 Kuwait Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 118 Rest of MEA Infertility Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 119 Heat Map Analysis
Fig. 120 Strategic Framework
